Literature DB >> 10470916

Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT.

B I Yuh1, R H Cohan.   

Abstract

Although helical CT offers greater flexibility in data acquisition and reconstruction than does conventional axial CT, new opportunities for error must be understood so that optimal protocols are used that minimize the likelihood of misdiagnosis. Most nonrenal abdominal helical CT scans are obtained late in the corticomedullary phase of renal enhancement because of the preferable enhancement of other parenchymal organs. CT evaluation of the kidneys during the corticomedullary phase or at an intermediate phase between the corticomedullary and nephrographic phases has significant limitations. Therefore, dedicated renal CT performed for the detection of suspected renal masses or for the characterization of known renal masses must include images obtained during later phases of enhancement (i.e., nephrographic or excretory phase). Nephrographic or excretory phase images appear to be similar to one another but superior to corticomedullary phase images in the ability to both detect and characterize renal masses. Corticomedullary phase images should always be obtained when information about the renal vasculature is desired or when there is a possibility that a detected renal mass may represent an aneurysm or an arteriovenous malformation or fistula. Optimal technique of helical CT for staging renal cancers may require use of both corticomedullary and nephrographic or excretory phase images, although work in this area is still preliminary.

Entities:  

Mesh:

Year:  1999        PMID: 10470916     DOI: 10.2214/ajr.173.3.10470916

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  [Modern imaging modalities in renal disease: CT and MRI].

Authors:  P Rogalla; M Taupitz; B Hamm
Journal:  Urologe A       Date:  2003-02-01       Impact factor: 0.639

2.  Virtual nonenhanced abdominal dual-energy MDCT: Analysis of image characteristics.

Authors:  Jacob Sosna; Shmuel Mahgerefteh; Liran Goshen; Galit Kafri; Galit Aviram; Arye Blachar
Journal:  World J Radiol       Date:  2012-04-28

3.  Dose reduction in multidetector CT of the urinary tract. Studies in a phantom model.

Authors:  E Coppenrath; T Meindl; P Herzog; R Khalil; U Mueller-Lisse; L Krenn; M Reiser; U G Mueller-Lisse
Journal:  Eur Radiol       Date:  2006-03-28       Impact factor: 5.315

Review 4.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

5.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

6.  A novel use of attenuation value (Hounsfield unit) in non-contrast CT: diagnosis of pyonephrosis in obstructed systems.

Authors:  Ismail Basmaci; Ertugrul Sefik
Journal:  Int Urol Nephrol       Date:  2019-09-20       Impact factor: 2.370

Review 7.  Imaging and Screening of Kidney Cancer.

Authors:  Alberto Diaz de Leon; Ivan Pedrosa
Journal:  Radiol Clin North Am       Date:  2017-11       Impact factor: 2.303

Review 8.  [Modern imaging of kidney tumors].

Authors:  D-A Clevert; A Sterzik; M Braunagel; M Notohamiprodjo; A Graser
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

9.  Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Authors:  Leo G Flores; Hsin-Hsien Yeh; Suren Soghomonyan; Daniel Young; James Bankson; Qianghua Hu; Mian Alauddin; Vicki Huff; Juri G Gelovani
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

Review 10.  Multidetector CT of the kidney.

Authors:  E M Coppenrath; U G Mueller-Lisse
Journal:  Eur Radiol       Date:  2006-03-28       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.